title: Medical treatment of endocrine gastroenteropancreatic tumors.
authors.affiliation: Department of Internal Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy. paola.tomassetti@unibo.it
authors.forename: Paola
authors.initials: P
authors.lastname: Tomassetti
authors.forename: Davide
authors.initials: D
authors.lastname: Campana
authors.forename: Francesca
authors.initials: F
authors.lastname: Nori
authors.forename: Lidya
authors.initials: L
authors.lastname: Piscitelli
authors.forename: Luisa
authors.initials: L
authors.lastname: Salomone
authors.forename: Raffaele
authors.initials: R
authors.lastname: Pezzilli
authors.forename: Roberto
authors.initials: R
authors.lastname: Corinaldesi
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D015282:Octreotide / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D016499:Radioimmunotherapy; D013004:Somatostatin / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D016898:Interferon-alpha; D013004:Somatostatin; D015282:Octreotide